Elena M. Spevak
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Elena M. Spevak has a total of 24 co-authors. Here are the top co-authors by number of shared publications:
- D.J. Hristoforando
Stavropol State Medical University Ministry of Health of Russia; City clinical hospital of emergency medical care
8 shared publications - Sergey O. Ivanyuta
Stavropol State Medical University Ministry of Health of Russia
4 shared publications Dmitry Christoforando
Stavropol State Medical University
2 shared publications- Kristina S. Gandylyan
Stavropol State Medical University Ministry of Health of Russia
2 shared publications - R.S. Spevak
Ставропольская краевая клиническая больница, 355029, Ставрополь, Россия
2 shared publications - A. V. Ermakova
Stavropol Regional Clinical Oncology Dispensary
1 shared publication
Latest Publications
- Open Access
- 2 May 2026
- Published by Alfmed LLC in Medical alphabet
- No. 10,p. 28-34
Analysis of the microbial picture in medication-related osteonecrosisof the jaws
Medication-related osteonecrosis of the jaws is an extremely severe complication that occurs after taking bisphosphonates, particularly zoledronic acid. Many studies have shown that oral microorganisms play a significant role in the pathogenesis and development of the inflammatory process associated with this complication. Actinomycetes are frequently detected in bone samples from patients with this condition. This article analyzes the results of a microbiological study in patients with medication-related osteonecrosis of the jaws, comparing them to post-traumatic osteomyelitis and chronic odontogenic osteomyelitis. Data on the susceptibility of microorganisms to various antibacterial agents are also analyzed. It has been established that medication-related osteonecrosis of the jaws is characterized by a wide diversity of microorganisms, including Streptococcus viridans, Staphylococcus aureus, Actinomyces species, and a number of other representatives of the oral microflora. The microbial picture in drug-induced osteonecrosis of the jaws has features of both odontogenic and stomatogenic processes. The presence of actinomycetes likely aligns it with the odontogenic type. Due to the difficulties in culturing actinomycetes, preliminary microscopy to detect mycelium and pathohistological methods are preferred for their diagnosis. In drug-induced osteonecrosis of the jaws, Staphylococcus aureus is resistant to cephalosporin antibiotics; second-generation fluoroquinolones (ciprofloxacin, levofloxacin) have proven most effective. When Streptococcus viridans was detected in cultures from patients with drug-induced osteonecrosis of the jaws, penicillin and second- to fourth-generation cephalosporins, as well as doxycycline, were the most effective antibacterial agents. The presence of actinomycetes in the pathogenesis of drug-induced osteonecrosis of the jaws has been confirmed and requires further study.
- 2 May 2026
- Published by Alfmed LLC in Medical alphabet
- No. 10,p. 28-34
Open AccessAnalysis of the microbial picture in medication-related osteonecrosisof the jaws
Medication-related osteonecrosis of the jaws is an extremely severe complication that occurs after taking bisphosphonates, particularly zoledronic acid. Many studies have shown that oral microorganisms play a significant role in the pathogenesis and development of the inflammatory process associated with this complication. Actinomycetes are frequently detected in bone samples from patients with this condition. This article analyzes the results of a microbiological study in patients with medication-related osteonecrosis of the jaws, comparing them to post-traumatic osteomyelitis and chronic odontogenic osteomyelitis. Data on the susceptibility of microorganisms to various antibacterial agents are also analyzed. It has been established that medication-related osteonecrosis of the jaws is characterized by a wide diversity of microorganisms, including Streptococcus viridans, Staphylococcus aureus, Actinomyces species, and a number of other representatives of the oral microflora. The microbial picture in drug-induced osteonecrosis of the jaws has features of both odontogenic and stomatogenic processes. The presence of actinomycetes likely aligns it with the odontogenic type. Due to the difficulties in culturing actinomycetes, preliminary microscopy to detect mycelium and pathohistological methods are preferred for their diagnosis. In drug-induced osteonecrosis of the jaws, Staphylococcus aureus is resistant to cephalosporin antibiotics; second-generation fluoroquinolones (ciprofloxacin, levofloxacin) have proven most effective. When Streptococcus viridans was detected in cultures from patients with drug-induced osteonecrosis of the jaws, penicillin and second- to fourth-generation cephalosporins, as well as doxycycline, were the most effective antibacterial agents. The presence of actinomycetes in the pathogenesis of drug-induced osteonecrosis of the jaws has been confirmed and requires further study.
- 2 April 2026
- Published by Alfmed LLC in Medical alphabet
- No. 1
Comparative analysis of models of medication-related osteonecrosis of the jaw in a rodent experiment. Literature review
Bisphosphonates and denosumab are effective antiresorptive drugs that are included in clinical guidelines for the treatment of osteoporosis, as well as metastatic bone damage in cancer patients, both in our country and abroad. Their use is justified for the treatment and prevention of pathological fractures, hypercalcemia, and chronic pain syndrome. Osteonecrosis of the jaw is a serious complication of the use of antiresorptive drugs. The development of this complication has been successfully confirmed in experiments on rodents, information about which has been analyzed using PubMed databases and eLIBRARY.RU. Modeling of medication-related osteonecrosis of the jaw is an important stage in the study of this problem and allows us to trace the links of pathogenesis, the possibilities of diagnosis, treatment and prevention. The review analyzes various nuances of the experiment on modeling medication-related osteonecrosis of the jaw in rodents: the choice of a drug and its combinations with potentiating substances, the use of various surgical triggers, the author’s interpretation of the results obtained in terms of common terminology and staging of medication-related osteonecrosis of the jaw, as well as the results of various types of studies of the obtained tissue samples. The main issue of implementing such experiments – the selection of the dosage of zoledronic acid – is also discussed in detail in this article. The variety of different approaches of researchers to the reproduction of osteonecrosis of the jaw against the background of the use of antiresorptive agents is evidence of the hard work of numerous laboratories around the world and confirms that this problem is far from being solved. A standardized model of medication-related osteonecrosis of the jaw in rodents that accurately reflects the clinical conditions has not been developed to date.
- 2 April 2026
- Published by Alfmed LLC in Medical alphabet
- No. 1
Comparative analysis of models of medication-related osteonecrosis of the jaw in a rodent experiment. Literature review
Bisphosphonates and denosumab are effective antiresorptive drugs that are included in clinical guidelines for the treatment of osteoporosis, as well as metastatic bone damage in cancer patients, both in our country and abroad. Their use is justified for the treatment and prevention of pathological fractures, hypercalcemia, and chronic pain syndrome. Osteonecrosis of the jaw is a serious complication of the use of antiresorptive drugs. The development of this complication has been successfully confirmed in experiments on rodents, information about which has been analyzed using PubMed databases and eLIBRARY.RU. Modeling of medication-related osteonecrosis of the jaw is an important stage in the study of this problem and allows us to trace the links of pathogenesis, the possibilities of diagnosis, treatment and prevention. The review analyzes various nuances of the experiment on modeling medication-related osteonecrosis of the jaw in rodents: the choice of a drug and its combinations with potentiating substances, the use of various surgical triggers, the author’s interpretation of the results obtained in terms of common terminology and staging of medication-related osteonecrosis of the jaw, as well as the results of various types of studies of the obtained tissue samples. The main issue of implementing such experiments – the selection of the dosage of zoledronic acid – is also discussed in detail in this article. The variety of different approaches of researchers to the reproduction of osteonecrosis of the jaw against the background of the use of antiresorptive agents is evidence of the hard work of numerous laboratories around the world and confirms that this problem is far from being solved. A standardized model of medication-related osteonecrosis of the jaw in rodents that accurately reflects the clinical conditions has not been developed to date.
- 3 March 2025
- Published by Alfmed LLC in Medical alphabet
- No. 1,p. 77-81
Analysis of the results of a microbiological study in patients with postcovid-19 necrosis of the maxillofacial region
Postcovoid necrosis of the maxillofacial region is a severe complication of the new coronavirus infection, characterized by an inflammatory process in the paranasal sinuses in combination with necrosis of the bones of the middle zone of the face (upper jaw, nasal concha, zygomatic bone). Many studies provide information that this complication is associated with fungal lesions of the organs of the middle zone of the face with mucormycetes (mucormycosis). The article provides an analysis of the results of a microbiological study of the excretory cavity of the mouth, nasal cavity and maxillary sinus in patients with postcovoid necrosis of the maxillofacial region in comparison with patients with bisphosphonate osteonecrosis of the maxilla, chronic rhinosinusitis, as well as patients with severe COVID-19 who do not have signs of necrosis. Mucormycetes were detected only in samples from 4 patients (18%) with postcovoid necrosis of the maxillofacial region, which did not confirm the hypothesis of the predominant role of this microorganism in the pathogenesis of the complication.
- 3 March 2025
- Published by Alfmed LLC in Medical alphabet
- No. 1,p. 77-81
Analysis of the results of a microbiological study in patients with postcovid-19 necrosis of the maxillofacial region
Postcovoid necrosis of the maxillofacial region is a severe complication of the new coronavirus infection, characterized by an inflammatory process in the paranasal sinuses in combination with necrosis of the bones of the middle zone of the face (upper jaw, nasal concha, zygomatic bone). Many studies provide information that this complication is associated with fungal lesions of the organs of the middle zone of the face with mucormycetes (mucormycosis). The article provides an analysis of the results of a microbiological study of the excretory cavity of the mouth, nasal cavity and maxillary sinus in patients with postcovoid necrosis of the maxillofacial region in comparison with patients with bisphosphonate osteonecrosis of the maxilla, chronic rhinosinusitis, as well as patients with severe COVID-19 who do not have signs of necrosis. Mucormycetes were detected only in samples from 4 patients (18%) with postcovoid necrosis of the maxillofacial region, which did not confirm the hypothesis of the predominant role of this microorganism in the pathogenesis of the complication.
- 27 February 2025
- Published by Alfmed LLC in Medical alphabet
- No. 1,p. 30-33
Analysis of the sensitivity to antibacterial drugs of the most significant microorganisms in postcovoid lesions of the maxillofacial region
Currently, there are numerous reports in the world and in Russia about a serious complication of the new coronavirus infection – extensive damage to the soft tissue and bone structures of the middle zone of the face. This complication is polyethological in nature and is caused by immunosuppression due to the severe course of COVID-19, high doses of glucocorticosteroids, hyperglycemia, against which an opportunistic infectious necrotic process develops a second time caused by various microorganisms, including fungi of the genus Mucorales, as well as various bacterial flora. The article provides an analysis of the sensitivity to antibacterial drugs of the most significant microorganisms in postcovoid lesions of the maxillofacial region, which were isolated as a result of microbiological research, namely Klebsiella pneumonia and Streptococcus viridans. The main criteria for choosing antimicrobial therapy for this pathology are also formulated.
- 27 February 2025
- Published by Alfmed LLC in Medical alphabet
- No. 1,p. 30-33
Analysis of the sensitivity to antibacterial drugs of the most significant microorganisms in postcovoid lesions of the maxillofacial region
Currently, there are numerous reports in the world and in Russia about a serious complication of the new coronavirus infection – extensive damage to the soft tissue and bone structures of the middle zone of the face. This complication is polyethological in nature and is caused by immunosuppression due to the severe course of COVID-19, high doses of glucocorticosteroids, hyperglycemia, against which an opportunistic infectious necrotic process develops a second time caused by various microorganisms, including fungi of the genus Mucorales, as well as various bacterial flora. The article provides an analysis of the sensitivity to antibacterial drugs of the most significant microorganisms in postcovoid lesions of the maxillofacial region, which were isolated as a result of microbiological research, namely Klebsiella pneumonia and Streptococcus viridans. The main criteria for choosing antimicrobial therapy for this pathology are also formulated.
- Open Access
- 30 November 2023
- Published by TIRAZH Publishing House in Actual problems in dentistry
- Vol. 19 (3) , 75-79
DEPENDENCE OF LEVELS OF BONE METABOLISM MARKERS ON THE STAGE OF MEDICATION-RELATED OSTEONECROSIS OF THE JAWS
- 30 November 2023
- Published by TIRAZH Publishing House in Actual problems in dentistry
- Vol. 19 (3) , 75-79
Open AccessDEPENDENCE OF LEVELS OF BONE METABOLISM MARKERS ON THE STAGE OF MEDICATION-RELATED OSTEONECROSIS OF THE JAWS
- 24 July 2023
- Published by ECO-Vector LLC in Kazan medical journal
- Vol. 104 (4) , 552-563
Postcovid necrosis of the cranio-maxillofacial region
The review article is devoted to one of the new topical problems in medicine necrosis of the organs of the cranio-maxillofacial region in patients with coronavirus infection, which was first discussed at the end of 2020. Later, doctors of various specialties (otolaryngologists, ophthalmologists, maxillofacial surgeons, neurosurgeons, dentists) from many countries of the world met in their practice with inflammatory-necrotic lesions of the mucous membrane of the nasal cavity and paranasal sinuses, facial skeleton and skull, eyeball, brain. The article highlights the main points of view of scientists about the etiology and pathogenesis of the studied pathology. Summarized data from the largest studies on the epidemiology, risk factors, and symptoms of post-covid necrosis of the cranio-maxillofacial region are presented. The results of various methods for diagnosing this complication multislice computed tomography, magnetic resonance imaging, angiography, are described in detail. Due to the fact that today the role of fungal flora is recognized as the leading one in the etiology of post-covid necrosis of the cranio-maxillofacial region, much attention is paid to cytological, microbiological and pathohistological research methods, which should be aimed at the search for mycelium. The main approaches to the treatment of patients with this pathology are formulated. The article highlights issues important for practical healthcare: interpretation of national clinical guidelines for coronavirus infection in terms of post-covid necrosis of the cranio-maxillofacial region, classification options according to the International Classification of Diseases of the 10th revision, the procedure for providing medical care to this category of patients, the economic consequences of the lack of active prevention methods of the presented complication in patients with COVID-19.
- 24 July 2023
- Published by ECO-Vector LLC in Kazan medical journal
- Vol. 104 (4) , 552-563
Postcovid necrosis of the cranio-maxillofacial region
The review article is devoted to one of the new topical problems in medicine necrosis of the organs of the cranio-maxillofacial region in patients with coronavirus infection, which was first discussed at the end of 2020. Later, doctors of various specialties (otolaryngologists, ophthalmologists, maxillofacial surgeons, neurosurgeons, dentists) from many countries of the world met in their practice with inflammatory-necrotic lesions of the mucous membrane of the nasal cavity and paranasal sinuses, facial skeleton and skull, eyeball, brain. The article highlights the main points of view of scientists about the etiology and pathogenesis of the studied pathology. Summarized data from the largest studies on the epidemiology, risk factors, and symptoms of post-covid necrosis of the cranio-maxillofacial region are presented. The results of various methods for diagnosing this complication multislice computed tomography, magnetic resonance imaging, angiography, are described in detail. Due to the fact that today the role of fungal flora is recognized as the leading one in the etiology of post-covid necrosis of the cranio-maxillofacial region, much attention is paid to cytological, microbiological and pathohistological research methods, which should be aimed at the search for mycelium. The main approaches to the treatment of patients with this pathology are formulated. The article highlights issues important for practical healthcare: interpretation of national clinical guidelines for coronavirus infection in terms of post-covid necrosis of the cranio-maxillofacial region, classification options according to the International Classification of Diseases of the 10th revision, the procedure for providing medical care to this category of patients, the economic consequences of the lack of active prevention methods of the presented complication in patients with COVID-19.
- Open Access
- 18 July 2023
- Published by Clinical Dentistry in Clinical Dentistry (Russia)
- Vol. 26 (2) , 76-85
Terminology and classification of medication-related osteonecrosis of the jaws (review)
За прошедшие 20 лет в ключевых аспектах терминологии и классификации остеонекроза челюстей, ассоциированного с приемом лекарственных препаратов, произошли серьезные метаморфозы, которые отразили трансформацию понимания проблемы исследователями разных стран. На сегодняшний день наиболее распространенным и общеупотребительным определением данного патологического процесса является предложенное Американской ассоциацией хирургов-стоматологов и челюстно-лицевых хирургов (AAOMS) в 2014 г. — «остеонекроз челюстей, связанный с лекарствами» — Medication-Related Osteonecrosis of the Jaw (MRONJ). Критерии установки диагноза медикаментозного остеонекроза челюстей по AAOMS (2014): 1) текущее или предыдущее лечение антирезорбтивными (остеомодицирующими) или антиангиогенными препаратами; 2) обнаженная кость или кость, которую можно прозондировать через внутри- или внеротовой свищ в челюстно-лицевой области, сохраняющаяся более 8 недель; 3) в анамнезе нет лучевой терапии в области головы и шеи или явного метастатического поражения челюстей. Наиболее известная классификация медикаментозного остеонекроза челюстей была предложена AAOMS в 2007 г., она включает 5 категорий пациентов (группа риска, 0, 1, 2, 3 стадия). Отличительная особенность классификации AAOMS — подчеркнута роль воспалительного процесса при MRONJ, переводящего заболевание в более тяжелую стадию. Существует также принципиально иная классификация остеонекроза челюстей, предложенная Итальянским обществом патологии полости рта и медицины (SIPMO) совместно с Итальянским обществом челюстно-лицевых хирургов (SICMF) в 2013 г., в ней выделены 3 стадии заболевания. Классификация SIPMO/SICMF рассматривает остеонекроз челюстей не только как деструктивно-некротический, но и как склеротический процесс, протекающий от ограниченных форм до диффузных с развитием осложнений. Основные спорные на сегодняшний день моменты по вопросам терминологии и классификации медикаментозного остеонекроза челюстей: возможность объединения медикаментозного и токсического остеонекроза челюстей в одну патологию, место рентгенологического метода в определении случая заболевания, необходимость проведения биопсии при остеонекрозе челюстей, дискуссия о так называемой 0-й стадии — неэкспонированного варианта заболевания (без оголения кости), принципы построения классификаций в зависимости от разных признаков. Данные приводятся в соответствии с позиционными документами, а также с клиническими рекомендациями по медикаментозному остеонекрозу челюстей ведущих мировых научно-медицинских сообществ. Over the past 20 years, key aspects of the terminology and classification of drug-associated osteonecrosis of the jaws have undergone major metamorphoses that have reflected a transformation in the understanding of the problem by researchers in various countries. To date, the most common and commonly used definition of this pathological process is the Medication-Related Osteonecrosis of the Jaw (MRONJ) proposed by the American Association of Oral and Maxillofacial Surgeons (AAOMS) in 2014. The criteria for establishing a diagnosis of drug-induced osteonecrosis of the jaws according to AAOMS (2014) are: 1) current or previous treatment with antiresorptive (osteomodifying) or antiangiogenic drugs; 2) exposed bone or bone that can be probed through an intraoral or extraoral fistula in the maxillofacial region that persists for more than 8 weeks; 3) there is no history of radiation therapy in the head and neck area or an obvious metastatic lesion of the jaws. The most well-known classification of drug-induced osteonecrosis of the jaws is the classification proposed by AAOMS in 2007, which includes 5 categories of patients (risk group, 0, 1, 2, 3 stages). A distinctive feature of the AAOMS classification is the emphasized role of the inflammatory process in MRONJ, which translates the disease into a more severe stage. There is also a fundamentally different...
- 18 July 2023
- Published by Clinical Dentistry in Clinical Dentistry (Russia)
- Vol. 26 (2) , 76-85
Open AccessTerminology and classification of medication-related osteonecrosis of the jaws (review)
За прошедшие 20 лет в ключевых аспектах терминологии и классификации остеонекроза челюстей, ассоциированного с приемом лекарственных препаратов, произошли серьезные метаморфозы, которые отразили трансформацию понимания проблемы исследователями разных стран. На сегодняшний день наиболее распространенным и общеупотребительным определением данного патологического процесса является предложенное Американской ассоциацией хирургов-стоматологов и челюстно-лицевых хирургов (AAOMS) в 2014 г. — «остеонекроз челюстей, связанный с лекарствами» — Medication-Related Osteonecrosis of the Jaw (MRONJ). Критерии установки диагноза медикаментозного остеонекроза челюстей по AAOMS (2014): 1) текущее или предыдущее лечение антирезорбтивными (остеомодицирующими) или антиангиогенными препаратами; 2) обнаженная кость или кость, которую можно прозондировать через внутри- или внеротовой свищ в челюстно-лицевой области, сохраняющаяся более 8 недель; 3) в анамнезе нет лучевой терапии в области головы и шеи или явного метастатического поражения челюстей. Наиболее известная классификация медикаментозного остеонекроза челюстей была предложена AAOMS в 2007 г., она включает 5 категорий пациентов (группа риска, 0, 1, 2, 3 стадия). Отличительная особенность классификации AAOMS — подчеркнута роль воспалительного процесса при MRONJ, переводящего заболевание в более тяжелую стадию. Существует также принципиально иная классификация остеонекроза челюстей, предложенная Итальянским обществом патологии полости рта и медицины (SIPMO) совместно с Итальянским обществом челюстно-лицевых хирургов (SICMF) в 2013 г., в ней выделены 3 стадии заболевания. Классификация SIPMO/SICMF рассматривает остеонекроз челюстей не только как деструктивно-некротический, но и как склеротический процесс, протекающий от ограниченных форм до диффузных с развитием осложнений. Основные спорные на сегодняшний день моменты по вопросам терминологии и классификации медикаментозного остеонекроза челюстей: возможность объединения медикаментозного и токсического остеонекроза челюстей в одну патологию, место рентгенологического метода в определении случая заболевания, необходимость проведения биопсии при остеонекрозе челюстей, дискуссия о так называемой 0-й стадии — неэкспонированного варианта заболевания (без оголения кости), принципы построения классификаций в зависимости от разных признаков. Данные приводятся в соответствии с позиционными документами, а также с клиническими рекомендациями по медикаментозному остеонекрозу челюстей ведущих мировых научно-медицинских сообществ. Over the past 20 years, key aspects of the terminology and classification of drug-associated osteonecrosis of the jaws have undergone major metamorphoses that have reflected a transformation in the understanding of the problem by researchers in various countries. To date, the most common and commonly used definition of this pathological process is the Medication-Related Osteonecrosis of the Jaw (MRONJ) proposed by the American Association of Oral and Maxillofacial Surgeons (AAOMS) in 2014. The criteria for establishing a diagnosis of drug-induced osteonecrosis of the jaws according to AAOMS (2014) are: 1) current or previous treatment with antiresorptive (osteomodifying) or antiangiogenic drugs; 2) exposed bone or bone that can be probed through an intraoral or extraoral fistula in the maxillofacial region that persists for more than 8 weeks; 3) there is no history of radiation therapy in the head and neck area or an obvious metastatic lesion of the jaws. The most well-known classification of drug-induced osteonecrosis of the jaws is the classification proposed by AAOMS in 2007, which includes 5 categories of patients (risk group, 0, 1, 2, 3 stages). A distinctive feature of the AAOMS classification is the emphasized role of the inflammatory process in MRONJ, which translates the disease into a more severe stage. There is also a fundamentally different...
- Open Access
- 22 May 2023
- Published by TIRAZH Publishing House in Actual problems in dentistry
- Vol. 19 (1) , 87-91
DIFFERENCES IN THE MICROBIOLOGICAL PICTURE IN PATIENTS WITH POST-COVID OSTEONECROSIS OF THE MAXILLOFACIAL REGION AND THE RISK GROUP FOR THIS COMPLICATION
Subject. Postcovid necrosis of the maxillofacial region is one of the severe consequences of a new coronavirus infection, the etiology and pathogenesis of which are not fully understood. A large number of researchers emphasize the leading role of molds in the development of this complication, which they characterize as COVID-19-associated rhino-orbito-cerebral mycosis. However, there is a point of view that the inflammatory process in post-covid necrosis can also be caused by other pathogens - saprophytic microflora. The aim of the study was to evaluate the results of microbiological examination in patients with Postcovid necrosis of the maxillofacial region and in the risk group for this complication. Methodology. The main study group consisted of 19 patients with signs of osteonecrosis of the bones of the facial skeleton and inflammatory lesions of the paranasal sinuses after suffering a coronavirus infection (Postcovid necrosis of the maxillofacial region). Control group (risk group) - 32 patients with severe COVID-19 without the above manifestations. A microbiological study was performed - a smear from the mucous membrane in the region of the middle nasal passage, smear microscopy, seeding on standard and elective (Saburo) media before treatment. Data were compared using Fisher's exact test for p<0.05. Results. In the main group there were 19 people - 10 men (52.63%), 9 women (47.37%), aged 54 to 73 years, in the control group - 18 (56.25%) men, 14 (43, 75%) women, 52 to 83 years old. In the main group, Streptococcus viridans, Klebsiella pneumonia and Mucor spp. were detected significantly more often (p<0.05), and Staphylococcus aureus was found in the risk group. Mycelium of mold fungi was found only in 3 patients of the main group, in the rest the absence of fungal invasion was confirmed cytologically and pathohistologically. Conclusions. The data obtained confirm the assumption that the inflammatory process in Postcovid necrosis of the maxillofacial region can be caused by various pathogens and is an opportunistic nosocomial infection. It is required to monitor patients at risk and timely treatment if they develop specific symptoms.
- 22 May 2023
- Published by TIRAZH Publishing House in Actual problems in dentistry
- Vol. 19 (1) , 87-91
Open AccessDIFFERENCES IN THE MICROBIOLOGICAL PICTURE IN PATIENTS WITH POST-COVID OSTEONECROSIS OF THE MAXILLOFACIAL REGION AND THE RISK GROUP FOR THIS COMPLICATION
Subject. Postcovid necrosis of the maxillofacial region is one of the severe consequences of a new coronavirus infection, the etiology and pathogenesis of which are not fully understood. A large number of researchers emphasize the leading role of molds in the development of this complication, which they characterize as COVID-19-associated rhino-orbito-cerebral mycosis. However, there is a point of view that the inflammatory process in post-covid necrosis can also be caused by other pathogens - saprophytic microflora. The aim of the study was to evaluate the results of microbiological examination in patients with Postcovid necrosis of the maxillofacial region and in the risk group for this complication. Methodology. The main study group consisted of 19 patients with signs of osteonecrosis of the bones of the facial skeleton and inflammatory lesions of the paranasal sinuses after suffering a coronavirus infection (Postcovid necrosis of the maxillofacial region). Control group (risk group) - 32 patients with severe COVID-19 without the above manifestations. A microbiological study was performed - a smear from the mucous membrane in the region of the middle nasal passage, smear microscopy, seeding on standard and elective (Saburo) media before treatment. Data were compared using Fisher's exact test for p<0.05. Results. In the main group there were 19 people - 10 men (52.63%), 9 women (47.37%), aged 54 to 73 years, in the control group - 18 (56.25%) men, 14 (43, 75%) women, 52 to 83 years old. In the main group, Streptococcus viridans, Klebsiella pneumonia and Mucor spp. were detected significantly more often (p<0.05), and Staphylococcus aureus was found in the risk group. Mycelium of mold fungi was found only in 3 patients of the main group, in the rest the absence of fungal invasion was confirmed cytologically and pathohistologically. Conclusions. The data obtained confirm the assumption that the inflammatory process in Postcovid necrosis of the maxillofacial region can be caused by various pathogens and is an opportunistic nosocomial infection. It is required to monitor patients at risk and timely treatment if they develop specific symptoms.
- 28 March 2023
- Published by Stomatology for All - International Dental Review in Stomatology for all / International Dental Review
- No. 1(102)
Comparative evaluation of the effectiveness of light activation of photosensitizers in photodynamic therapy of periodontitis using different wavelengths
Dentists are always in quest of new methods for the treatment of periodontal diseases, and photodynamic therapy (PDT) is considered one of the most effective methods. A significant improvement in the clinical pic-ture was obtained in all patients throughout the control period of observation of the patients as a result of the treatment with the use of PDT. According to the data from research study it can be said that photodynamic therapy is an effective and gentle method of antibacterial treatment of inflammatory periodontal diseases, which can be effectively used to prevent exacerbations of chronic inflammatory periodontal diseases, to achieve a long-term positive effect and to refuse, in some cases, from surgical methods of treatment. There is a signifi-cant increase in the duration of remission of the disease, improvement of microcirculatory blood circulation in per-iodontal tissues and a small microbial contamination of periodontal pockets of patients treated with photodynam-ic therapy in the long term compared with groups of patients treated with only antiseptic and antibacterial drugs.
- 28 March 2023
- Published by Stomatology for All - International Dental Review in Stomatology for all / International Dental Review
- No. 1(102)
Comparative evaluation of the effectiveness of light activation of photosensitizers in photodynamic therapy of periodontitis using different wavelengths
Dentists are always in quest of new methods for the treatment of periodontal diseases, and photodynamic therapy (PDT) is considered one of the most effective methods. A significant improvement in the clinical pic-ture was obtained in all patients throughout the control period of observation of the patients as a result of the treatment with the use of PDT. According to the data from research study it can be said that photodynamic therapy is an effective and gentle method of antibacterial treatment of inflammatory periodontal diseases, which can be effectively used to prevent exacerbations of chronic inflammatory periodontal diseases, to achieve a long-term positive effect and to refuse, in some cases, from surgical methods of treatment. There is a signifi-cant increase in the duration of remission of the disease, improvement of microcirculatory blood circulation in per-iodontal tissues and a small microbial contamination of periodontal pockets of patients treated with photodynam-ic therapy in the long term compared with groups of patients treated with only antiseptic and antibacterial drugs.
- Open Access
- 15 July 2022
- Published by Bashkir State Medical University in Creative surgery and oncology
- Vol. 12 (2) , 151-158
Prevention Of Drug-Induced Osteonecrosis Of The Jaw In Cancer Patients
The occurrence of drug-induced osteonecrosis of the jaw in cancer patients treated using bone-modifying medications (bisphosphonates and denosumab) is a highly relevant research problem studied by dentists, maxillofacial surgeons, and oncologists. Despite the large number of publications, practical approaches to preventing drug-induced osteonecrosis of the jaw remain to be developed, which is confirmed by the increasing prevalence and severity of the clinical course of the disease. In this article, we review the most significant works and position papers published in Russia and abroad over the past 10 years, as well as the authors’ scientific and clinical experience, in order to identify key reasons behind the ineffective prevention of drug-induced osteonecrosis of the jaw in cancer patients and to suggests possible solutions. Questions concerning the legal protection of patients and clinicians in relation to this complication are discussed. Most recent achievements in the field of laboratory diagnostics and risk assessment of drug-induced osteonecrosis of the jaw in cancer patients, including the determination of bone metabolism markers, are presented. The following criteria for the safe use of bisphosphonates and denosumab in cancer patients were identified: dental screening; clinical and laboratory monitoring; individualizing drug dosage, duration and withdrawal regimens; application of an interdisciplinary approach.
- 15 July 2022
- Published by Bashkir State Medical University in Creative surgery and oncology
- Vol. 12 (2) , 151-158
Open AccessPrevention Of Drug-Induced Osteonecrosis Of The Jaw In Cancer Patients
The occurrence of drug-induced osteonecrosis of the jaw in cancer patients treated using bone-modifying medications (bisphosphonates and denosumab) is a highly relevant research problem studied by dentists, maxillofacial surgeons, and oncologists. Despite the large number of publications, practical approaches to preventing drug-induced osteonecrosis of the jaw remain to be developed, which is confirmed by the increasing prevalence and severity of the clinical course of the disease. In this article, we review the most significant works and position papers published in Russia and abroad over the past 10 years, as well as the authors’ scientific and clinical experience, in order to identify key reasons behind the ineffective prevention of drug-induced osteonecrosis of the jaw in cancer patients and to suggests possible solutions. Questions concerning the legal protection of patients and clinicians in relation to this complication are discussed. Most recent achievements in the field of laboratory diagnostics and risk assessment of drug-induced osteonecrosis of the jaw in cancer patients, including the determination of bone metabolism markers, are presented. The following criteria for the safe use of bisphosphonates and denosumab in cancer patients were identified: dental screening; clinical and laboratory monitoring; individualizing drug dosage, duration and withdrawal regimens; application of an interdisciplinary approach.